首页> 外文期刊>中华医学杂志(英文版) >Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism
【24h】

Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism

机译:通心络预处理通过一氧化氮相关机制保护猪心肌免受缺血/再灌注损伤

获取原文
获取原文并翻译 | 示例
           

摘要

Background The traditional Chinese medicine Tongxinluo can protect myocardium against ischaemia/reperfusion injury, but the mechanism of its action is not well documented. We examined the involvement of nitric oxide in the protective role of Tongxinluo. Methods Miniswine were randomized to four groups of seven: sham, control, Tongxinluo and Tongxinluo coadministration with a nitric oxide synthase inhibitor Nω-nitro-L-arginine (L-NNA, 10 mg/kg i.v.). Three hours after administration of Tongxinluo, the animals were anaesthetised and the left anterior descending coronary artery ligated and maintained in situ for 90 minutes followed by 3 hours of reperfusion before death. Area of no reflow and necrosis and risk region were determined pathologically by planimetry. The degree of neutrophil accumulation in myocardium was obtained by measuring myeloperoxidase activity and histological analysis. Myocardial endothelial nitric oxide synthase activity and vascular endothelial cadherin content were measured by colorimetric method and immunoblotting analysis respectively.Results Tongxinluo significantly increased the local blood flow and limited the infarct and size of no reflow. Tongxinluo also attenuated myeloperoxidase activity and neutrophil accumulation in histological sections and maintained the level of vascular endothelial cadherin and endothelial nitric oxide synthase activity in the reflow region when compared with control group. The protection of Tongxinluo was counteracted by coadministration with L-NNA. Conclusions Tongxinluo may limit myocardial ischaemia and protect the heart against reperfusion injury. Tongxinluo regulates synthesis of nitric oxide by altering activity of endothelial nitric oxide synthase.
机译:背景技术中药通心络可以保护心肌免受缺血/再灌注损伤,但其作用机理尚未得到充分证实。我们研究了一氧化氮在通心络的保护作用中的作用。方法将小猪随机分为四组,每组七组:假,对照组,通心络和通心络与一氧化氮合酶抑制剂Nω-硝基-L-精氨酸(L-NNA,10 mg / kg静脉内)合用。给予通心络后3小时,将动物麻醉,并结扎左冠状动脉前降支并原位维持90分钟,然后再灌注3小时,直至死亡。通过平面法通过病理学确定无回流的区域和坏死区域以及危险区域。通过测量髓过氧化物酶活性和组织学分析来获得中性粒细胞在心肌中的积累程度。用比色法和免疫印迹法分别测定心肌内皮一氧化氮合酶活性和血管内皮钙粘蛋白含量。结果通心络显着增加了局部血流量,限制了梗死面积和无复流的大小。与对照组相比,通心络还减弱了组织切片中的髓过氧化物酶活性和中性粒细胞积聚,并维持了回流区域的血管内皮钙黏着蛋白和内皮一氧化氮合酶活性。与L-NNA并用可抵消通心络的保护作用。结论通心络可限制心肌缺血,保护心脏免受再灌注损伤。通心络通过改变内皮型一氧化氮合酶的活性来调节一氧化氮的合成。

著录项

  • 来源
    《中华医学杂志(英文版)》 |2009年第13期|1529-1538|共10页
  • 作者单位

    Department of Cardiology,Peking Union Medical College,Fuwai Hospital and Cardiovascular Institute,and Chinese Academy of Medical Sciences,Beijing 100037,China;

    Department of Cardiology,Peking Union Medical College,Fuwai Hospital and Cardiovascular Institute,and Chinese Academy of Medical Sciences,Beijing 100037,China;

    Department of Cardiology,Peking Union Medical College,Fuwai Hospital and Cardiovascular Institute,and Chinese Academy of Medical Sciences,Beijing 100037,China;

    Department of Cardiology,Peking Union Medical College,Fuwai Hospital and Cardiovascular Institute,and Chinese Academy of Medical Sciences,Beijing 100037,China;

    Department of Cardiology,Peking Union Medical College,Fuwai Hospital and Cardiovascular Institute,and Chinese Academy of Medical Sciences,Beijing 100037,China;

    Core Laboratory,Peking Union Medical College,Fuwai Hospital and Cardiovascular Institute,and Chinese Academy of Medical Sciences,Beijing 100037,China;

    Experimental Animal Center,Peking Union Medical College,Fuwai Hospital and Cardiovascular Institute,and Chinese Academy of Medical Sciences,Beijing 100037,China;

    The Integration of Traditional and Western Medical Research Academy of Hebei Province,No.238 Tianshan Street,Hi-tech Development Zone,Shijiazhuang,Hebei 050035,China;

  • 收录信息 中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 内科学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号